Purpose
Therapeutic Drug Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80375
New York State Approval Status

Approved

Turnaround Time

4 days

Test Includes
1 Pregabalin Lyrica® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) mcg/mL 0.1 Anticonvulsant, Antiepileptic

Specimen Type
Serum or Plasma
Requested Volume
1 mL
Minimum Volume
0.4 mL
Special Handling
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 1 month(s)
Refrigerated: 1 month(s)
Frozen (-20 °C): 12 month(s)
1 Pregabalin Lyrica® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) mcg/mL 0.1 Anticonvulsant, Antiepileptic

Interface Map

LOINC® Information